| John A Lafferty, LMSW | |
|
8704 Blairwood Rd Apt B2, Nottingham, MD 21236-2396 | |
| (202) 683-0049 | |
| Not Available |
| Full Name | John A Lafferty |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 8704 Blairwood Rd Apt B2, Nottingham, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013573500 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 20196 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John A Lafferty, LMSW 8704 Blairwood Rd Apt B2, Nottingham, MD 21236-2396 Ph: (202) 683-0049 | John A Lafferty, LMSW 8704 Blairwood Rd Apt B2, Nottingham, MD 21236-2396 Ph: (202) 683-0049 |
News Archive
Sutter Health, one of California's largest health care givers, fraudulently charged insurers up to hundreds of millions of dollars over the past decade for anesthesia services that in some cases weren't even provided, the state's insurance commissioner said Wednesday (Allday, 4/14).
A review in the July/August issue of "CA: A Cancer Journal for Clinicians" reports that two out of three survivors of childhood cancer have at least one chronic or late-occurring health problem following their cancer therapy, with about one in three having serious or life-threatening complications. These effects are often seen decades after therapy.
This year, the Miami Beach symposium kicked off on a rainy Friday with a new name and a new focus on biomarkers. For seven years, the meeting has been called the Mild Cognitive Impairment Symposium, but that changed this year to the Symposium on Early Alzheimer's Disease. The change comes as a nod to a recent and dramatic shift in how Alzheimer disease is perceived, and what researchers increasingly see as the most promising angle of attack for future therapeutics.
Astellas Pharma US, Inc., U.S. subsidiary of Astellas Pharma Inc., today announced the results of a pivotal phase III clinical trial for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder (OAB), which show mirabegron significantly improves key OAB symptoms – urinary incontinence and frequency of micturition compared with placebo.
Clinical trials of the anti-cancer agent PAC-1 are continuing to expand, thanks to a $7 million angel investment from an anonymous contributor who originally invested $4 million to help get the compound this far in the drug-approval pipeline.
› Verified 6 days ago
Ms. Margot Allen, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 4308 Bedrock Cir Apt 101, Nottingham, MD 21236 Phone: 443-834-2306 | |
Ms. Shanine A. Borum, LCSWC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24 Bellfalls Way, Nottingham, MD 21236 Phone: 410-782-1888 | |
Rachel Matthews, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 5022 Campbell Blvd # 4969, Nottingham, MD 21236 Phone: 443-442-1568 | |
Johanne Elaine Etienne Zawitoski, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9649 Belair Rd Ste 104, Nottingham, MD 21236 Phone: 410-529-1309 Fax: 410-529-1005 | |
Bailey Pararas, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9649 Belair Rd Ste 104, Nottingham, MD 21236 Phone: 410-529-1309 Fax: 410-529-1005 | |
Nicole Kafka, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7939 Honeygo Blvd Ste 224, Nottingham, MD 21236 Phone: 410-933-9700 |